CROI 2013: Health Insurance Coverage Linked to HIV Viral Load Suppression [VIDEO]
- Details
- Category: HIV Treatment
- Published on Tuesday, 05 March 2013 00:00
- Written by Gregory Fowler
Whether people with HIV have health insurance -- and the type of coverage they have -- influences the likelihood of viral suppression, according to a poster presentation Tuesday at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
Coverage of the 2013 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Monday, 04 March 2013 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), March 3-6, 2013, in Atlanta.
Conference highlights include HIV experimental therapies and treatment strategies, HIV cure research, HIV-related conditions and complications, treatment as prevention and PrEP, new treatments for hepatitis C, and HIV/HBV and HIV/HCV coinfection.
HIVandHepatitis.com CROI 2013 conference section
3/4/13
CROI 2013: VOICE Trial's Disappointing Result Poses Big Questions for PrEP
- Details
- Category: HIV Prevention
- Published on Monday, 04 March 2013 00:00
- Written by Gus Cairns
The failure of one of the largest trials yet conducted of HIV drug-based prevention methods poses questions for how to turn vaginal microbicides and oral pre-exposure prophylaxis (PrEP) into methods people can actually use, the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta heard today.
CROI 2013: Progress in Hepatitis C Drug Development [VIDEO]
- Details
- Category: Experimental HCV Drugs
- Published on Monday, 04 March 2013 00:00
- Written by Gregory Fowler
Hepatitis C and its treatment has been a key focus at the 20th Conference on Retroviruses and Opportunistic Infections(CROI 2013), taking place this week in Atlanta. Investigators gave an overview of their research and projections about forthcoming approvals of direct-acting antiviral agents at a morning press conference on Monday.
CROI 2013: Development of Small Molecules for HIV Eradication [VIDEO]
- Details
- Category: Experimental HIV Drugs
- Published on Monday, 04 March 2013 00:00
- Written by Gregory Fowler
Research towards a cure for HIV is a key theme of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), taking place this week in Atlanta. One of the many approaches under study is the use of small molecules to bring resting HIV out of latency, in an effort to ultimately eradicate the virus from the body.
Web Design and Development by